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In this issue of PiAP we can read the invited 
systematic review on telemonitoring in COPD by 
Claudio Pedone and Diana Lelli from Università 
Campus Bio-Medico di Roma [1]. The authors 
have extraordinary experience in the field, they 
have published several papers on the topic, 
including a randomized controlled trial on the 
efficacy of telemonitoring in elderly patients with 
COPD [2]. In this study they showed reduced 
rate of exacerbations and COPD-related hospital 
admissions in patients followed up with the aid 
of a multiparametric remote monitoring system 
compared to patients followed up using the stan-
dard model of care. They concluded, that these 
results should be replicated and confirmed on 
a bigger cohort of COPD patients. This beneficial 
effect of telemonitoring was recently confirmed 
by Mierdel and Owen [3].
In the face of a shortage of big randomized 
trials, the statistical power to prove that teleme-
dicine is efficacious and cost-effective could be 
improved by metaanalysis. So far at least two 
metaanalyses on this topic have been published 
[4, 5]. Polisena et al. [4] concluded, that home 
telehealth (home telemonitoring and telephone 
support) reduces rates of hospitalization and 
emergency department visits, while findings for 
hospital bed days of care varied between studies. 
Unexpectedly, the mortality rate was greater in 
the telephone-support group compared with 
usual care. Home telehealth interventions were 
similar or better than usual care for quality of 
life and patient satisfaction outcomes. Authors 
stress out the substantial heterogeneity of clinical 
outcomes measured by different authors, which 
made it difficult to draw unequivocal conclusions. 
Kitsiou et al. [5], who evaluated the potential role 
of telemonitoring in different chronic disorders 
(including COPD), point out that further efforts 
should be made to improve the design, conduct, 
reporting, and publication of systematic reviews 
and meta-analyses in this area. The current sys-
tematic review by Pedone and Lelli summarizes 
and updates the current knowledge in this par-
ticular field, however the conclusions are still 
the same. The authors say: “our study confirms 
that the available evidence on the effectiveness 
of telemedicine in COPD does not allow to draw 
definite conclusions; most evidence suggests 
a positive effect of telemonitoring on hospital ad-
missions and ER visits. More trials with adequate 
sample size and with adequate consideration of 
background clinical services are needed to defi-
nitively establish its effectiveness”.
What parameters should be monitored by 
telemedical systems in COPD patients? The list 
is almost endless. Starting from the most obvious 
clinical parameters like FEV1 or PEF measured by 
portable spirometer or PEF-meter, SatO2 measu-
red by pulsoximeter, blood pressure, heart rate, 
through diurnal change of symptoms estimated 
by use of simple questionnaires, up to registration 
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of behavioral changes, which may anticipate up-
coming adverse event, i.e. disease exacerbation, 
need of hospital admission or even sudden death. 
Even an unexpected loss of compliance in data 
reporting may be a good measure of health status 
deterioration. 
The next question is which patients should 
be subjected to telemonitoring first. Will it be 
potentially useful and economically justified to 
monitor all COPD patients? It seems reasonable to 
preselect with caution these patients who would 
benefit the most. Will it be a good solution for 
those, who exacerbate frequently? Or only those, 
who experience severe exacerbations or require 
hospitalization? Or only these patients with very 
high risk of death during upcoming exacerbation, 
i.e. with previous ICU admissions? In this case 
the destination group would be C and D category. 
But why not to monitor patients from category B, 
who have much more vascular comorbidities and 
the highest risk of death due to non-respiratory 
causes [6]. In this case, would it be reasonable in 
these patients to focus on cardiovascular rather, 
than respiratory parameters. 
Different approaches have been proposed. 
Hernandez et al. [7] applied so-called Integrated 
Care Services in the project targeted to patients 
with COPD, cardiac failure and/or type 2 diabe-
tes. This ambitious project included evaluation 
of: (1) enhanced care to prevent hospitalization, 
(2) home hospitalization and early discharge, 
(3) home-based maintenance of rehabilitation 
effects, and (4) support for remote diagnosis. The 
authors showed high potential of the four inte-
grated care services to enhance health outcomes 
with cost-containment. This project indicated the 
possibility and even need of more complex and 
universal approach to telemonitoring of patients 
with multiple chronic coexistent disorders, ho-
wever it also generated new methodological and 
practical problems.
Quite different approach was proposed by 
Blumenthal et al. [8], who compared in a ran-
domized clinical trial coping skills training 
intervention (by helping them develop skills for 
coping more effectively with their disease) with 
COPD education for improving QoL and medical 
outcomes in COPD patients. The authors conc-
luded, that a telehealth coping skills training 
intervention produced clinically meaningful 
improvements in quality of life and functional 
capacity, but no overall improvement in risk of 
COPD-related hospitalization and all-cause mor-
tality. This study is an example, by what different 
means the goals could be achieved. 
There are many unanswered or even unasked 
questions. Paradoxically, it is only a proof that 
we are at the very beginning of this journey. The 
standardization is the key issue. 
Completely different application of telemedi-
cine in pulmonology was proposed by Nowiński 
et al. (in this issue) [9]. The authors evaluated the 
use of spirometers with data transfer for training 
purposes. The telespirometric system was verified 
as a tool for spirometry training in family doctors’ 
offices, and was found useful and effective.
It is obvious, that future will bring further 
development of IT technologies, and in consequ-
ence new and more technically and scientifically 
advanced techniques will be available for tele-
medicine. It is also of no doubt, that IT devices 
and services are becoming cheaper and cheaper. 
This is a good environment for the research on 
the application of these techniques in medicine. 
COPD, due to its prevalence and high costs gene-
rated for health care system is a natural candidate 
for this research. Let us move in the same pace 
with IT researchers.
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